Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Lee Website

Chyi-Chia Richard Lee, M.D., Ph.D.

Selected Publications
1)  Liu Y, Liu Q, Rosenberg SA, Lee CR.
Immunohistochemical staining of KBA.62 in metastatic malignant melanoma (12th joint meeting of the International Society of Dermatopathology).
Volume . In Press. [Meeting Proceeding]
2)  Sobanko JF, Freeman AF, Palmore TN, Mendoza D, Lee CR, Cowen EW.
A Sri Lankan female with rheumatoid arthritis and anesthetic plaques.
Journal of the American Academy of Dermatology. 2008. In Press. [Journal]
3)  McDermott DF, Gammon B, Snijders PJ, Mbata I, Phifer B, Hartley AH, Lee CR, Murphy PM, Hwang ST.
Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
Pediatric Dermatology. 2008. In Press. [Journal]
4)  Hedrick MN, Lonsdorf AS, Shirakawa A, Lee CR, Liao F, Singh SP, Grinberg A, Love PE, Hwang ST, Farber JM.
CCR6 is required for IL-23-induced psoriasis-like inflammation.
The Journal of Clinical Investigation. 2008. In Press. [Journal]
5)  Oh U, Blevins G, Griffith C, Richert N, Maric D, Lee CR, McFarland H, Jacobson S.
Regulatory T cells are reduced during anti-CD25 antibody treatment for multiple sclerosis.
Archives of Neurology. 2008. In Press. [Journal]
6)  Pemov A, Park C, Lee C, Moshyedi A, Messiaen L, Yao L, Upadhyaya M, Sloan J, Stewart D.
Bi-allelic inactivation of NF1 and genomic architecture in two NF1-associated glomus tumors (Children's Tumor Foundation annual meeting NF Conference).
Volume . June 6-10, 2008; Bonita Springs, Florida. p. 1. [Meeting Proceeding]
7)  Kesserwan C, Sokolic RA, Heselmeyer K, Ortiz-Melendez C, Cohen J, Jagadeesh J, Garabedian E, Baird K, Wayne AS, Cowen EW, Pittaluga S, Lee CR, Sherry R, Bridge J, Finlayson L, Walsh N, Issekutz A, Candotti F.
Dermatofibrosarcoma Protuberans in 3 patients with ADA-SCID (50th Annual meeting of the American Society of Hematology).
Volume 112. December 6-9, 2008; San Francisco. p. 1. [Meeting Proceeding]
8)  Mahindra P, DiGiovanna JJ, Tamura D, Brahim JS, Hornyak TJ, Stern JB, Lee CC, Khan SG, Brooks BP, Smith JA, Driscoll BP, Montemarano AD, Sugarman K, Kraemer KH.
Skin cancers, blindness, and anterior tongue mass in African brothers.
J. Am. Acad. Dermatol. 59: 881-6, 2008. [Journal]
9)  Torres-Cabala CA, DeWitt CA, Stabinski L, DeCastro R, Holland S, Turner ML, Lee CR.
Acquired Acrodermatitis Enteropathica in a Patient with Multiple Nutrient Deficiencies After Gastric Bypass (10th joint meeting of the International Society of Dermatopathology).
Volume . January 31-February 1, 2007; Washington, DC. p. 1. [Meeting Proceeding]
10)  Lee CR, Tresera F, Merino MJ.
Carcinoma of Mammary-Like Glands of the Vulva Arising at the Site of a Syringoma (10th joint meeting of the International Society of Dermatopathology).
Volume . January 31-February 1, 2007; Washington, DC. p. 1. [Meeting Proceeding]
11)  Sloan J, Park C, Moshyedi A, Yao L, Lee C, Stewart D.
Clinical characterization of 3 patients with NF1 and suspected glomus tumors (57th Annual Meeting of The American Society of Human Genetics).
Volume . October 23-27, 2007; San Diego. p. 1. [Meeting Proceeding]
12)  Karai LJ, Stern JB, Lee CR, Rosenberg SA, Turner ML.
Clinical, Histological and Immunohistochemical Findings in Two Patients Receiving Melanoma Antigen Specific Immunotherapy and Presenting with Diffusely Erythematous, Edematous/Vesicular and Purpuric Rash Sparing Vitiliginous Areas (10th joint meeting of the International Society of Dermatopathology).
Volume . January 31-February 1, 2007; Washington, DC. p. 1. [Meeting Proceeding]
13)  Lee CR, Shamburek RD, Turner ML.
Xanthoma Eruptiva Annulare: A Very Rare and Unusual Presentation of Eruptive Xanthoma (44th annual meeting of The American Society of Dermatopathology).
Volume . October 18-21, 2007; Baltimore. p. 1. [Meeting Proceeding]
14)  Lee CR, Reed JA, Huttenbach Y.
Pleomorphic hyalinizing angiectactic tumor of soft parts: a case report (43rd annual meeting of The American Society of Dermatopathology).
Volume . October 26-29, 2006; Chicago. p. 1. [Meeting Proceeding]
15)  Lee CR, Huttenbach Y, Reed JA.
Subcutaneous Metastasis From Choriocarcinoma of the Testis (42nd Annual Meeting of The American Society of Dermatopathology).
Volume 33. October 20-23, 2005; Seattle. p. 95. [Meeting Proceeding]
16)  Bellucci K, Xu X, Lee C, Pasha T, Elenitsas R, Elder D, Zhang P.
D2-40 Immunoreactivity in Spindle Cell Tumors, a Specific Lymphatic Endothelial Marker? (United States and Canadian Academy of Pathology annual meeting).
Volume . March 6-12, 2004; Vancouver. p. 1. [Meeting Proceeding]
17)  Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, Trink B.
DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
Cancer Res. 63: 2351-7, 2003. [Journal]
18)  Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D.
Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.
Cancer Res. 63: 2216-22, 2003. [Journal]
19)  Lee CR, Schoenberg M, Westra WH, Hudson MA, Lerner SP, Messing EM, Sidransky D.
A prospective, randomized, multi-institutional trial for the molecular detection and monitoring of urinary bladder cancer patients (92nd annual meeting of the American Association for Cancer Research).
Volume . March 24-28, 2001; New Orleans. p. 1. [Meeting Proceeding]
20)  Trink B, Buta M, Lee CR, Ratovitski E, Patturajan M, Jan J, Sidransky D.
Downstream targets of the p53 homologue, p40 (91st annual meeting of the American Association for Cancer Research).
Volume . April 1-5, 2000; San Francisco. p. 1. [Meeting Proceeding]
21)  Medintz IL, Lee CC, Wong WW, Pirkola K, Sidransky D, Mathies RA.
Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis.
Genome Res. 10: 1211-8, 2000. [Journal]
22)  Yamamoto S, Min W, Lee CC, Salim EI, Wanibuchi H, Sukata T, Fukushima S.
Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Cancer Lett. 135: 137-44, 1999. [Journal]
23)  Ichihara T, Wanibuchi H, Lee CC, Nakajima K, Yano Y, Taniyama T, Otani S, Shimizu Y, Fukushima S.
Lack of inhibitory effects of the Ju-myo protein on development of glutathione S-transferase placental form-positive foci in the male F344 rat liver.
The Journal of toxicological sciences. 24: 27-31, 1999. [Journal]
24)  Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S.
Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Jpn. J. Cancer Res. 90: 818-23, 1999. [Journal]
25)  Lee CC, Wanibuchi H, Yamamoto S, Hirose M, Hayashi Y, Fukushima S.
Molecular cytogenetic identification of cyclin D1 gene amplification in a renal pelvic tumor attributed to phenacetin abuse.
Pathol. Int. 49: 648-52, 1999. [Journal]
26)  Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S.
Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Carcinogenesis. 20: 1697-708, 1999. [Journal]
27)  Yamamoto S, Romanenko A, Wei M, Masuda C, Zaparin W, Vinnichenko W, Vozianov A, Lee CC, Morimura K, Wanibuchi H, Tada M, Fukushima S.
Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
Cancer Res. 59: 3606-9, 1999. [Journal]
28)  Romanenko A, Lee CC, Yamamoto S, Hori T, Wanibuchi H, Zaparin W, Vinnichenko W, Vozianov A, Fukushima S.
Urinary bladder lesions after the Chernobyl accident: immunohistochemical assessment of p53, proliferating cell nuclear antigen, cyclin D1 and p21WAF1/Cip1.
Jpn. J. Cancer Res. 90: 144-53, 1999. [Journal]
29)  Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S. Chappell W, Abernathy C, Calderon R, eds.
Differences of Promoting Activity and Loss of Heterozygosity Between Dimethylarsinic Acid and Sodium L-Ascorbate in F1 Rat Urinary Bladder Carcinogenesis. In: Arsenic Exposure and Health Effects. Volume 1.
San Diego: Elsevier; 1998. p. 263-277 [Book Chapter]
30)  Lee CC, Masuda C, Yamamoto S, Wanibuchi H, Ikemoto S, Sugimura K, Nakatani T, Wada S, Kishimoto T, Fukushima S.
Assessment of cell cycle-related elements p53, p21WAF1/Cip1, cyclin D1 and PCNA in a mixed transitional cell carcinoma and adenocarcinoma of the renal pelvis: a case report.
Jpn. J. Clin. Oncol. 28: 227-32, 1998. [Journal]
31)  Harimoto K, Sugimura K, Lee CR, Kuratsukuri K, Kishimoto T.
In vivo gene transfer methods in the bladder without viral vectors.
British journal of urology. 81: 870-4, 1998. [Journal]
32)  Lee CC, Fukushima S.
Review article Alterations in cyclin D1, p53, and the cell cycle related elements: Implications for distinct genetic pathways of urinary bladder carcinogenesis.
Urologic Oncology. 4: 58-72, 1998. Full Text Article. [Journal]
33)  Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Cancer Res. 57: 4765-76, 1997. [Journal]
34)  Sugimura K, Lee CC, Kim T, Goto T, Kasai S, Harimoto K, Yamagami S, Kishimoto T.
Production of hepatocyte growth factor is increased in chronic renal failure.
Nephron. 75: 7-12, 1997. [Journal]
35)  Otori K, Yano Y, Takada N, Lee CC, Hayashi S, Otani S, Fukushima S.
Reversibility and apoptosis in rat urinary bladder papillomatosis induced by uracil.
Carcinogenesis. 18: 1485-9, 1997. [Journal]
36)  Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T, Fukushima S.
Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
Cancer. 79: 780-9, 1997. [Journal]

This page was last updated on 1/16/2009.